The North America asset performance management market stood at $760 million in 2025 and is forecast to expand to $2,110 million by 2035, registering a CAGR of 10.8% over the 2026–2035 period. The North America APM market is gaining traction as enterprises expand digital capabilities and integrate advanced technologies that enable predictive and performance?driven asset management. Cloud computing and artificial intelligence (AI) adoption are central to this shift, providing scalable infrastructure and analytics that help organisations monitor asset health, predict failures, and optimise maintenance workflows. 

Global non-small cell lung cancer market was valued at $18.4 billion in 2024 and is growing at a CAGR of 6.4% during the forecast period (2026-2035). Accelerated regulatory approvals for targeted therapies are significantly changing the NSCLC treatment landscape, offering quicker access to new oral treatments for patients with specific genetic mutations who have progressed after prior systemic therapies. This expedited access broadens treatment options in advanced disease stages and stimulates market growth; this regulatory momentum is increasingly reflected in recent approval decisions. For instance, in August 2025, the US FDA granted accelerated approval to Boehringer's HERNEXEOS (zongertinib tablets), the first orally administered targeted therapy for adults with HER2-mutant advanced non-small cell lung cancer (NSCLC) who have previously undergone systemic therapy. 

Europe generic drugs market was valued at $123.4 billion in 2024 and is projected to reach $201.9 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2025-2035). The European generic drug market is increasingly shaped by stringent regulatory frameworks, high consumer expectations for safety and efficacy, and growing demand for cost-effective therapeutic solutions. Oversight by the European Medicines Agency (EMA) and compliance with Good Manufacturing Practices (GMP) ensure high-quality formulations and bioequivalence, fostering trust among patients and healthcare providers. Companies are focusing on innovation in complex generics, specialty dosage forms, and injectable formulations to meet evolving treatment needs, while promoting accessibility and affordability across diverse Western, Central, and Eastern European markets. Rising awareness of sustainable practices and environmentally responsible manufacturing further supports adoption and brand credibility.

Global HFO refrigerant market was valued at $6,267 million in 2025 and is growing at a CAGR of 18.2% during the forecast period (2026-2035). The HVACR industry is undergoing a structural transition toward low-global warming potential (GWP) refrigerants, driven by the need to reduce environmental impact while maintaining system performance across comfort cooling, commercial refrigeration, and transport refrigeration applications. This shift has accelerated the adoption of hydrofluoroolefin (HFO)-based refrigerants, which offer a balance of lower emissions, energy efficiency, and compatibility with existing equipment.

Global fetal bovine serum market was valued at $2.1 billion in 2025 and is growing at a CAGR of 13.3% during the forecast period (2026-2035). Fetal Bovine Serum (FBS) is a common supplement in cell culture, providing essential nutrients, growth factors, and hormones that support cell proliferation and viability. In the context of IVF and fertility treatments, FBS can be used in laboratory processes such as embryo culture and sperm preservation, helping maintain cell health and promoting successful fertilization in vitro. While effective, its use raises ethical concerns and variability issues, leading some laboratories to explore serum-free or humanized alternatives.

Global colorectal cancer diagnosis and therapeutics market was valued at $13.6 billion in 2025 and is growing at a CAGR of 4.5% during the forecast period (2026-2035). Regulatory support through fast-track designations and expedited review pathways plays a key role in driving growth in the global colorectal cancer diagnosis and therapeutics market by enabling faster patient access to novel and effective treatments. Such initiatives encourage the development and adoption of targeted therapies, particularly those addressing specific genetic or molecular tumor profiles. For instance, in November 2025, the FDA granted Fast Track Designation to a new drug combination for metastatic colorectal cancer.

China polyvinylidene fluoride market was valued at $320.5 million in 2025 and is projected to reach $801.5 million by 2035, growing at a CAGR of 9.7% during the forecast period (2026–2035).The China PVDF market is growing rapidly, driven by rising demand from electric vehicles, energy storage systems, renewable energy, and advanced industrial applications, along with technological advancements in high-performance fluoropolymers. Among these factors, lithium-ion batteries stand out as the primary growth engine, as PVDF is essential both as a binder in electrodes and as a functional coating for separators.

North America narrow band IoT market was valued at $2,557.0 million in 2025 and is projected to reach $25,137.9 million by 2035, growing at a CAGR of 25.6% during the forecast period (2026–2035). The North American Narrowband IoT (NB-IoT) market is driven by increasing enterprise adoption for applications requiring reliable connectivity, secure data transmission, and operational efficiency. Key growth factors include secure LTE-grade connectivity, reliable urban and industrial performance, deep indoor coverage, and lower operational costs through carrier-managed networks. Whereas licensed networks are the primary driver by providing exclusive spectrum, predictable QoS, and enterprise-grade security while enabling scalable and risk-managed IoT deployments.

North America polyvinylidene fluoride market was valued at $252.4 million in 2025 and is projected to reach $592.9 million by 2035, growing at a CAGR of 8.9% during the forecast period (2026–2035). The North America polyvinylidene fluoride (PVDF) market is primarily driven by rising demand from lithium-ion batteries and electric vehicles, automotive and transportation applications, chemical processing and industrial equipment, electronics insulation and others. But Among these, regulatory mandates such as California’s SB 54 and state-level Extended Producer Responsibility (EPR) programs are emerging as the most significant growth driver, forcing a shift from multi-layer laminates to mono-material recyclable packaging formats, thereby structurally increasing PVDF adoption across packaging and high-performance applications.

global Telemedicine market was valued at $54.0 billion in 2025 and is projected to reach $113.1 billion by 2035, growing at a CAGR of 7.8% during the forecast period (2026-2035). The global telemedicine market is supported by rising healthcare demand, limited access to care, and advances in digital health platforms. However, the global healthcare workforce shortage remains the primary growth driver, as telemedicine improves physician productivity, extends specialist reach to underserved regions, and enables scalable care delivery without proportional increases in staffing.